Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,027 | -43,157 | -33,642 | -16,380 | -6,902 |
| Depreciation Amortization | 18 | 58 | 41 | 23 | 4 |
| Other Working Capital | -2,352 | 3,382 | 8,055 | 2,963 | 1,743 |
| Other Operating Activity | 755 | 1,805 | 1,211 | 787 | 352 |
| Operating Cash Flow | $-7,606 | $-37,911 | $-24,336 | $-12,607 | $-4,803 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -226 | -226 | -226 | -226 |
| Other Investing Activity | 0 | 0 | -200 | -200 | -200 |
| Investing Cash Flow | $0 | $-226 | $-426 | $-426 | $-426 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,514 | N/A | N/A | 0 | N/A |
| Common Stock Issued | N/A | 139 | 85 | 41 | N/A |
| Other Financing Activity | -538 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-6,052 | $139 | $85 | $41 | $N/A |
| Beginning Cash Position | 37,949 | 75,948 | 75,948 | 75,948 | 75,948 |
| End Cash Position | 24,290 | 37,949 | 51,270 | 62,955 | 70,718 |
| Net Cash Flow | $-13,659 | $-37,999 | $-24,677 | $-12,993 | $-5,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,606 | -37,911 | -24,336 | -12,607 | -4,803 |
| Capital Expenditure | N/A | -226 | -226 | -226 | -226 |
| Free Cash Flow | -7,606 | -38,138 | -24,562 | -12,833 | -5,030 |